| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 20,169 | 19,564 | 20,637 | 21,056 | | Cost of Revenue | 9,911 | 11,180 | 10,955 | 11,488 | | | Gross Profit | 10,258 | 8,384 | 9,682 | 9,568 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,482 | 8,397 | 9,000 | 9,032 | | Non Recurring | (729) | 220 | (220) | (323) | | Others | 259 | 263 | 269 | 501 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,246 | (496) | 633 | 358 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 104 | 370 | 673 | 470 | | Earnings Before Interest And Taxes | 2,350 | (126) | 1,306 | 828 | | Interest Expense |
-
|
-
|
-
| 854 | | Income Before Tax | 2,350 | (126) | 1,306 | (26) | | Income Tax Expense | 258 | 132 | 420 | 605 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,092 | (258) | 886 | (631) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,092 | (258) | 886 | (631) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,092 | ($258) | $886 | ($631) |
|
1.00% Nasdaq 
Income Statement
